Historical Stock Price
CTRV historical stock prices picture
CTRV (CTRV) has the following price history information. Looking back at CTRV historical stock prices for the last five trading days, on July 16, 2019, CTRV opened at $3.89, traded as high as $3.92 and as low as $3.65, and closed at $3.75. Trading volume was a total of 213.40K shares. On July 17, 2019, CTRV opened at $3.68, traded as high as $3.98 and as low as $3.65, and closed at $3.65. Trading volume was a total of 295.80K shares. On July 18, 2019, CTRV opened at $3.66, traded as high as $3.80 and as low as $3.57, and closed at $3.62. Trading volume was a total of 137.20K shares. On July 19, 2019, CTRV opened at $3.59, traded as high as $3.67 and as low as $3.56, and closed at $3.56. Trading volume was a total of 109.60K shares. On July 22, 2019, CTRV opened at $3.59, traded as high as $3.70 and as low as $3.53, and closed at $3.58. Trading volume was a total of 139.00K shares.

CTRV Historical Stock Prices By Date:

CTRV historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CTRV shares, starting with a $10,000 purchase of CTRV, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 07/22/2019
Start price/share: $1,316.00
End price/share: $3.58
Dividends collected/share: $0.00
Total return: -99.73%
Average Annual Total Return: -67.13%
Starting investment: $10,000.00
Ending investment: $27.19
Years: 5.31
Date Open High Low Close Volume
07/16/2019 $3.89 $3.92 $3.65 $3.75 213.40K
07/17/2019 $3.68 $3.98 $3.65 $3.65 295.80K
07/18/2019 $3.66 $3.80 $3.57 $3.62 137.20K
07/19/2019 $3.59 $3.67 $3.56 $3.56 109.60K
07/22/2019 $3.59 $3.70 $3.53 $3.58 139.00K
Hepion Pharmaceuticals is a biopharmaceutical company focused primarily on the clinical development and commercialization of targeted antiviral therapies with a specific focus on developing a potentially curative therapy for hepatitis B virus (HBV). Co. is developing two anti-HBV compounds with complementary mechanisms of action. Co.'s key compound, TXL™ is in development and is designed to deliver high intrahepatic concentrations of tenofovir (TFV), while minimizing off-target effects caused by high levels of circulating TFV. CRV431, Co.'s second compound for HBV, is a next-generation cyclophilin inhibitor with a structure that increases its selective index against TXL™.
Date Close
07/16/2019$3.75
07/17/2019$3.65
07/18/2019$3.62
07/19/2019$3.56
07/22/2019$3.58
CTRV is categorized under the Healthcare sector; below are some other companies in the same sector:

CTRX Historical Stock Prices
CTSO Historical Stock Prices
CTXR Historical Stock Prices
CUR Historical Stock Prices
CUTR Historical Stock Prices
CVD Historical Stock Prices
CVM Historical Stock Prices
CVRS Historical Stock Prices
CWBR Historical Stock Prices
CXM Historical Stock Prices

Also explore: CTRV shares outstanding history

Email EnvelopeFree CTRV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CTRV Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.